Research Areas
- Modulating myeloid derived suppressor cell function to alter response to checkpoint inhibition.
- Accounting for heterogeneity of the suppressive immune microenvironment according to tumor site
- Investigation of novel therapeutics targeting immunosuppressive cells
- Racial disparities of the immune response in breast cancer
Funding
- METAvivor-Early Career Investigator Award
- Tower Research Foundation -Career Development Award
- Concern Foundation- Conquer Cancer Now Award
- Concern Foundation- Minnie Ripperton Legacy Fund
- Wright Foundation Transformative Oncology Award
- USC Translational Immune Oncology Program Award
- USC Tumor Microenvironment Pilot Award
- USC Norris Comprehensive Cancer Center Core Voucher Program
Recent News
The Roussos Torres lab is recruiting new members! See Opportunities page for details.
USC Environmental Health & Safety: October 2022 Researcher Spotlight
Published in Cancer Immunology Research, USC Norris member Dr. Evanthia Roussos Torres and her colleagues discovered that entinostat decreases immune suppression and promotes antitumor responses against HER2+ breast tumors.
Facebook: www.facebook.com/uscnorriscancercenter/posts/466783968473403
Twitter: twitter.com/uscnorris/status/1500907651617619971
Instagram: www.instagram.com/p/Ca0DokCvdJ0/
Early Career Investigator Award by METAvivor Research and Support Inc.
Facebook: www.facebook.com/uscnorriscancercenter/posts/454658919685908
Twitter: twitter.com/uscnorris/status/1494031772081815552
Instagram: www.instagram.com/p/CaDM644PKdK/
Hopkins Medicine News Article: Inhibitor Drug Entinostat ‘Primes’ the Body to Better Respond to Anti-Cancer Treatment with Immunotherapy
Checkout an interview with Mr. Richard Rudolph and Mr. Derek Alpert discussing the inaugural award of the Minnie Ripperton Legacy Fund supporting promising young physician scientists studying breast cancer.
Dr. Roussos Torres speaks about her work and her inspirations during the Tower Research Foundation gala event
Featured on USC Norris Cancer Center: Meet our Members
Immunotherapy 101 – Tower Magazine: A long term goal of immunotherapy
is to significantly prolong the lives
of patients with breast cancer
without the toxicity of traditional
chemotherapy.